Implication of Stiffness of the Hamstrings, Achilles Tendon and Calf Muscles for Jumping Performance
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02842892 |
Recruitment Status :
Completed
First Posted : July 25, 2016
Last Update Posted : February 28, 2018
|
Tracking Information | |||
---|---|---|---|
First Submitted Date ICMJE | July 18, 2016 | ||
First Posted Date ICMJE | July 25, 2016 | ||
Last Update Posted Date | February 28, 2018 | ||
Study Start Date ICMJE | July 2016 | ||
Actual Primary Completion Date | April 2017 (Final data collection date for primary outcome measure) | ||
Current Primary Outcome Measures ICMJE |
Tissue Stiffness (calf muscles, achilles tendon, hamstring and patellar tendon) using two different tissue compliance meter (Indentometer Pro; Myoton Pro). [ Time Frame: 15 Min. ] | ||
Original Primary Outcome Measures ICMJE | Same as current | ||
Change History | |||
Current Secondary Outcome Measures ICMJE |
Jumping performance (counter movement jump, drop jump, squat jump) using a contact time mat (Refitronic) [ Time Frame: 10 Min ] | ||
Original Secondary Outcome Measures ICMJE | Same as current | ||
Current Other Pre-specified Outcome Measures | Not Provided | ||
Original Other Pre-specified Outcome Measures | Not Provided | ||
Descriptive Information | |||
Brief Title ICMJE | Implication of Stiffness of the Hamstrings, Achilles Tendon and Calf Muscles for Jumping Performance | ||
Official Title ICMJE | Not Provided | ||
Brief Summary | For optimal jumping performance an adequate interaction of muscles and tendons is required. A parameter in the functional evaluation of both structures is their stiffness (resistance of the tissue against deformation by external forces). It is unclear so far if higher stiffness values of tendon or muscle or a specific stiffness relation of both tissues is the cause of better jumping performance. The present study examines this based on the Achilles tendon and the calf muscles or the patellar tendon and the hamstrings by three different forms of jumps (squat jump, counter-Movement Jump, Drop-Jump). The plan is to include young healthy volunteers aged 18 to 40 years. In a cross-sectional study, the jump height of the participants will be measured for each jump form: squat jump (jump from a squatting position), Counter-Movement Jump (jump with backswing by going into the knees) or drop jump (jump from small box with direct re-jump). The order of the jump form is determined randomly. The measurements are carried out within one day. Furthermore the international physical activity questionnaire will be used in order to assess the level of physical activity. As primary outcome the stiffness of the calf muscles, achilles tendon, hamstring and patellar tendon will be detected. The measurement is carried out before the jumps (there are three jumps after one sample jump performed). The measurement is executed non-invasively and completely painless using Indentometers and MyotonPro. With both devices, minimal pressure on the examined tissue will be exerted and measured how much of this can be compressed. |
||
Detailed Description | Not Provided | ||
Study Type ICMJE | Interventional | ||
Study Phase ICMJE | Not Applicable | ||
Study Design ICMJE | Primary Purpose: Diagnostic | ||
Condition ICMJE | Tissue Compliance | ||
Intervention ICMJE | Other: Tissue stiffness | ||
Study Arms ICMJE |
|
||
Publications * | Not Provided | ||
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||
Recruitment Information | |||
Recruitment Status ICMJE | Completed | ||
Estimated Enrollment ICMJE |
35 | ||
Original Estimated Enrollment ICMJE | Same as current | ||
Actual Study Completion Date ICMJE | April 2017 | ||
Actual Primary Completion Date | April 2017 (Final data collection date for primary outcome measure) | ||
Eligibility Criteria ICMJE | Inclusion Criteria:
Exclusion Criteria:
|
||
Sex/Gender ICMJE |
|
||
Ages ICMJE | 18 Years to 65 Years (Adult, Older Adult) | ||
Accepts Healthy Volunteers ICMJE | Yes | ||
Contacts ICMJE | Contact information is only displayed when the study is recruiting subjects | ||
Listed Location Countries ICMJE | Germany | ||
Removed Location Countries | |||
Administrative Information | |||
NCT Number ICMJE | NCT02842892 | ||
Other Study ID Numbers ICMJE | SpM2016-004 | ||
Has Data Monitoring Committee | Not Provided | ||
U.S. FDA-regulated Product | Not Provided | ||
IPD Sharing Statement ICMJE | Not Provided | ||
Responsible Party | Prof. Dr. Dr. Winfried Banzer, Goethe University | ||
Study Sponsor ICMJE | Goethe University | ||
Collaborators ICMJE | Not Provided | ||
Investigators ICMJE | Not Provided | ||
PRS Account | Goethe University | ||
Verification Date | February 2018 | ||
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |